Search clinical trials for: SHR0302 Ointment

Total 571 results

Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis (MARBLE-23)

Atopic Dermatitis

China
Reistone Biopharma Company Limited

Terminated

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

Vitiligo

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis

Non-radiographic Axial Spondyloarthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

First-in-Human Single Ascending Dose of SHR0302

Rheumatoid Arthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Human Substance Balance and Biotransformation of [14C]SHR0302

Rheumatoid Arthritis (RA)

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A SHR0302 BA Study on Healthy Subjects

Autoimmune Diseases

China
Henan Cancer Hospital

Not yet recruiting

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Peripheral T Cell Lymphoma

China
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Alopecia Areata

Alopecia Areata

China, Australia, United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study on the Bioavailability of SHR0302 in Healthy Subjects

Healthy Subjects

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects

Rheumatoid Arthritis

China
Reistone Biopharma Company Limited

Completed

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

China
Reistone Biopharma Company Limited

Recruiting

A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

China, United States, Georgia, Poland, Ukraine
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

Alopecia Areata

China
Reistone Biopharma Company Limited

Completed

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

China, Canada
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Psoriatic Arthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

Hepatic Impairment

China
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

Ulcerative Colitis

China, Poland, Ukraine, United States, Puerto Rico
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Crohn's Disease

China, Poland, Ukraine, United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability

Graft-versus-host Disease

China
Pfizer

Completed

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Plaque Psoriasis | Atopic Dermatitis

United States, Canada, United Kingdom, Japan
Pfizer

Completed

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Dermatitis, Atopic

Australia
Yin-ku Lin

Completed

Comparison of Refined and Crude Indigo Naturalis Ointment in Treating Psoriasis

Psoriasis Vulgaris

Taiwan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Atopic Dermatitis

Japan
Serentis Ltd.

Completed

Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis

Atopic Dermatitis

Germany, Bulgaria, Finland
GlaxoSmithKline

Completed

A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis

Psoriasis

Germany
Pfizer

Completed

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis (EMPORIA)

Plaque Psoriasis | Atopic Dermatitis

United States, Australia, Canada, Poland
Dermavant Sciences GmbH

Completed

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Atopic Dermatitis

Canada, United States
Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

A Study for the Treatment of Dry Eye in Postmenopausal Women

Postmenopausal Women With DED

China
Pfizer

Completed

Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Stasis Dermatitis

United States
PharmaEssentia
PharmaEssentia Japan K.K.

Completed

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

Healthy Volunteer

Japan
Pfizer

Completed

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Psoriasis

United States
Dermavant Sciences GmbH

Completed

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
UNION therapeutics

Completed

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

Atopic Dermatitis

Bulgaria, Denmark, Poland
Pfizer

Completed

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Psoriasis

Mexico
Pfizer

Completed

Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis

Dermatitis, Atopic

Australia, United States
LEO Pharma

Completed

Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema

Hand Eczema

Germany
Pfizer

Completed

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Psoriasis

Mexico
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Meibomian Gland Dysfunction | MGD-Meibomian Gland Dysfunction

United States
RXi Pharmaceuticals, Corp.

Unknown

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

Plantar Warts | Common Warts | HPV (Human Papillomavirus) | Periungual Warts

United States
Technoderma Medicines Inc.
Therapeutics, Inc.

Not yet recruiting

Study of TDM-180935 in Atopic Dermatitis Patients

Atopic Dermatitis

United States
Tufts Medical Center
Pfizer

Withdrawn

Topical Crisaborole in Patients With Alopecia Areata

Alopecia Areata

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Hypertension
BioGaia AB

Completed

Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis

Atopic Dermatitis

South Africa
Dong-A University Hospital

Completed

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects

Colorectal Cancer | Pancreatic Cancer | Non-small Cell Lung Cancer

Korea, Republic of
LEO Pharma

Completed

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

Inverse Psoriasis

Germany

3

Subscribe